PLGA nanoparticles in drug delivery: the state of the art.
By I. Bala, S. Hariharan, Mnv Ravi Kumar. Critical reviews in therapeutic drug carrier systems, 2004
712 citations recorded by the source corpus.
Subfields: Artificial Intelligence, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/624904cd50a4a6cac797a7ef365e81cbe77f3a0c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Hanes
- K. Yue
- Ying-Ying Wang
- S. Lai
- Saghi Saghazadeh
- Ali Khademhosseini
- Chiara Rinoldi
- Ali Tamayol
Citations in the corpus
- Controlled drug delivery in tissue engineering. (2008, background): “, microparticles or nanoparticles), size distribution and morphology to tailor the release rate on the specific application, and their surface functionalized to enhance their interaction with cell and tissues [103–105].”
- Drug delivery systems: An updated review (2012, methodology): “Chitosan microspheres of 45-300 μ were used for controlled delivery of progesterone.[49] In vitro and in vivo release was tested.”
- Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. (2008, methodology): “, are successfully incorporated into PLGA or PLGAbased nano/microparticles [10–14].”
- Drug Delivery Systems and Materials for Wound Healing Applications (2018, positive): “By copolymerization of lactide and glycolide monomers with specific ratios (L:G), PLGA is obtained, which is one of the most popular materials for engineering drug carries [151, 152].”
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues (2008, background): “The dual capacity to form polyvalent adhesive interactions via both hydrophobic and anionic forces represents a particularly challenging problem for polymeric nanoparticles designed to deliver drugs and genes, since many commonly used biomaterials are either hydrophobic, such as poly(lactideco-glyco”
- Nanoparticle technology for drug delivery (2006, background): “Polymers commonly used in this process are poly(d,l-lactide-coglycolide (PLGA), poly(lactic acid) (PLA), and polymethacrylate (PMA) while stabilizers include polysorbate, polyvinyl alcohol, albumin, and poloxamer (Bala et al., 2004; O'Donnell and McGinity, 1997).”